Health
Existing drug masitinib identified as potential inhibitor of SARS-CoV-2 – News-Medical.Net
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COV…
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
The drug, which is called masitinib, potently inhibited the main viral protease 3CLpro that SARs-CoV-2 relies on for infection to proceed once the viral genome has entered the host cell cytoplasm.
The study showed that masitinib di…
-
General16 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General16 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General16 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News20 hours agoBrisbane rising on global rankings, but still behind southern capitals